Ibarra-Silva R, Sotelo-Cruz N, Hurtado-Valenzuela JG

Language: Spanish
References: 11
Page: 8-11
PDF size: 279.16 Kb.

ABSTRACT

Introduction: Goiter disease is defined as the thyroid gland overgrowth and the World Health Organization (WHO) has clasiffied it in three levels. Worlwide euthyroid goiter is the more frecuent presentation in children.
Objective: To know our frecuency of goiter disease at the Hospital Infantil del Estado de Sonora trying to define a clinical base criteria, anatomic and functional as well for the different types of goiter and their possible origins.
Material and Methods: We have revised 115 clinical records with the diagnosis of goiter disease, the following variable were included: age, sex, added symptoms, goiter level in the time of diagnosis, performed studies and final diagnosis.
Results: Of the 115 cases revised, 80% corresponded to females, being predominant in adolescents and 86% were asyntomatic at the time of their diagnosis, also the thyroid growth was the disease indicator. Clinical degree more frecuent were the third and second degree levels. Ecosonogram (71%) and thyroid function studios (100%), where the most frecuent used diagnostic methods.
Conclusions: Eutyroid goiter continues to be the most frecuent pathology in children, mainly in female adoles-cents. Thyroid function test and sonogram allow us the have a precise orientation regarding the origin of goiter and the necessity of complementing with another clinical studies.

REFERENCES

1. 1.- Ravibal FJL., Bueno LG. Endocrinología. Glándula Tiroides. Ed. McGraw Hill Interamericana; 1998. P. 59-90.

2. 2.- Pombo M, López -Siquero, Moreno -Molina JA. Bocios. Tratado de Endocrinología Pediátrica. Capitulo 34. Ed. McGraw Hill Interamericana; 2002. P. 570-83.

3. 3.- Garagarri JMA. Actitud ante los nódulos tiroideos. An Esp Pediatr. 2002; (56): 62-57.

4. 4.- Piñeiro LR, Torres GA, y cols. Biopsia aspirativa con aguja fina del Tiroides. Rev Cubana de Pediatr. 1996; (68), 2: 165-9.

5. 5.- Cían DM, Demarchi RV, Gay NC. Patología Tiroidea. Prevalencia de Patología Benigna y Maligna. Rev de Postg de la Vía Cat de Med. 2004; Febr. (135): 17-20.

6. 6.- Guzmán VB, Sotelo CN. Bocio eutiroideo: Importancia de su diagnóstico. Experiencia de 12 años en el Hospital Infantil del Estado de Sonora. Bol Clín Hosp Infant Edo Son. 1991; (8): 57-60.

7. 7.- Guzmán CM. Bocio Eutiroideo: 100 años de tratamiento. Rev Cubana Invest Biomed 1999; 18 (2): 138-45.

8. 8.- Borrajo GE, Pavia C, Gilbert A. Atlas de Endocrinología Pediátrica. Capítulo 5. Bocios en la Infancia y la Adoles-cencia. 1997: 325-46.

9. 9.- Martínez SH, Castañeda LR, Lechuga D, y cols. Deficiencia de Yodo y otros posibles bociógenos en la persistencia del bocio endémico en México. Gac Méd Méx. 2002; 138: 49-56.

10. 10.- Hernández SE, Torres AP, Normandia AMA y cols. Bocio endémico en México. Rev Endocrinol Nutr 1996; (4): 63-5.

11. 11.- Prettel EA, Aguirre A, Guell R, y cols. Consenso sobre los desórdenes por deficiencia de Yodo en Latinoamérica. Criterios de evaluación y monitoreo para su erradicación sostenida. Rev Cubana Endocrinol 1999; (2): 146-56.